论文部分内容阅读
目的:观察冠心病不稳定性心绞痛患者在使用了丹红注射液治疗后的临床疗效。方法:选取2014年1月至2015年7月于该院就诊的冠心病不稳定型心绞痛患者共80例,随机分为观察组和对照组各40例,给对照组患者采用丹参注射液进行治疗;给观察组患者采用丹红注射液进行治疗,对比两组患者的治疗效果。结果:两组患者在治疗后,对照组患者心电图数据有所变化,而观察组患者心电图数据较治疗前变化非常明显,二者组间差异明显(P<0.05);另外,对照组患者在接受治疗之后,总有效率为67.5%;观察组治疗的总有效率为95.0%。观察组患者的治疗效果明显要优于对照组(P<0.05)。结论:在治疗冠心病不稳定型心绞痛时,采用丹红注射液进行治疗能够有效的改善治疗效果,该药物值得大力推广。
Objective: To observe the clinical efficacy of Danhong injection in patients with coronary heart disease and unstable angina pectoris. Methods: A total of 80 patients with unstable angina pectoris who were admitted to our hospital from January 2014 to July 2015 were randomly divided into observation group (40 cases) and control group (40 cases). Patients in the control group were treated with Danshen injection The patients in the observation group were treated with Danhong injection, and the treatment effect was compared between the two groups. Results: The electrocardiogram data of the control group changed after the treatment, while the electrocardiogram data of the observation group changed more obviously than before treatment (P <0.05). In addition, in the control group, After treatment, the total effective rate was 67.5%; observation group, the total effective rate was 95.0%. The observation group patients treatment effect was significantly better than the control group (P <0.05). Conclusion: Danhong injection in the treatment of unstable angina pectoris can effectively improve the therapeutic effect, and the drug should be promoted.